A Study of DS-1471a In Subjects With Advanced Solid Tumors
A Phase 1, Multicenter, First-in-human Study of DS-1471a In Subjects With Advanced Solid Tumors
Sponsor: Daiichi Sankyo Co., Ltd.
Terminated
The study was terminated by the sponsor due to a business decision.
Other terminated trials from Daiichi Sankyo Co., Ltd.
- Netherton Syndrome · Phase PHASE1/PHASE2 · Jan 2025
- Malignant Peripheral Nerve Sheath Tumors · Phase PHASE1/PHASE2 · Oct 2024
- Gastrointestinal Stromal Tumors · Phase PHASE1 · Mar 2022
- Metastatic Colorectal Cancer · Phase PHASE2 · Feb 2022
- Acute Myeloid Leukemia · Phase PHASE1 · Apr 2021
More terminations from Daiichi Sankyo Co., Ltd.
Listed as NCT06074705, this PHASE1 trial focuses on Advanced Solid Tumor and remains terminated or withdrawn. Sponsored by Daiichi Sankyo Co., Ltd., it has been updated 10 times since 2023, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE1
-
May 2025 — Aug 2025 [monthly]
Recruiting PHASE1
-
Apr 2025 — May 2025 [monthly]
Recruiting PHASE1
-
Jan 2025 — Apr 2025 [monthly]
Recruiting PHASE1
▶ Show 5 earlier versions
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE1
-
Nov 2023 — Mar 2024 [monthly]
Recruiting PHASE1
First recorded
Aug 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Daiichi Sankyo Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .